STAT+: Brain biopsies on ‘vulnerable’ patients at Mount Sinai set off alarm bells at FDA, documents show
STAT
MAY 1, 2024
” At that point, he was living in a nursing home and had debilitating symptoms: tremors, difficulty gripping with his hands, and trouble walking. The FDA’s months-long internal examination of the LBP yielded a series of documents seen by STAT, including a lengthy review, completed in August 2019, of the Mount Sinai study.
135 
Let's personalize your content